Biologic and Mechanical Mitral Valve Prostheses: Outcomes in 50- to 69-Year-Olds
Howard C. Herrmann, MD reviewing Chikwe J et al. JAMA 2015 Apr 14.
Use of Clinical Factors Alone in Tailoring Edoxaban Dose in Atrial Fibrillation
Joel M. Gore, MD reviewing Ruff CT et al. Lancet 2015 Mar 10. Patel MR and Washam JB. Lancet 2015 Mar 10.
Vulnerable Patients with Aortic Stenosis: A 5-Year Perspective from PARTNER
Frederick A. Masoudi, MD, MSPH, FACC, FAHA reviewing Kapadia SR et al. Lancet 2015 Mar 15. Mack MJ et al. Lancet 2015 Mar 15. Kappetein AP. Lancet 2015 Mar 15.
Is Defibrillation Testing Necessary for All ICD Implants?
Mark S. Link, MD reviewing Healey JS et al. Lancet 2015 Feb. Singh JP and Holzmeister J. Lancet 2015 Feb.
Wait, Maybe One CHA2DS2-VASc Point Is a Concern
Mark S. Link, MD reviewing Chao TF et al. J Am Coll Cardiol 2015 Feb 24. Calkins H. J Am Coll Cardiol 2015 Feb 24.
Vorapaxar Has Greater Net Benefit in Patients with Diabetes
Howard C. Herrmann, MD reviewing Cavender MA et al. Circulation 2015 Feb 13.
Accuracy of Cardiovascular Risk Prediction Scores
Joel M. Gore, MD reviewing DeFilippis AP et al. Ann Intern Med 2015 Feb 17. Ridker PM and Cook NR. Ann Intern Med 2015 Feb 17.
Effect of Aging on Stem Cell Therapy in Ischemic Cardiomyopathy
Joel M. Gore, MD reviewing Golpanian S et al. J Am Coll Cardiol 2015 Jan 20.
Anticoagulation in Atrial Fibrillation: The U.S. Wins for Now
Mark S. Link, MD reviewing Friberg L et al. J Am Coll Cardiol 2015 Jan 27. Singer DE and Ezekowitz MD. J Am Coll Cardiol 2015 Jan 27.
Low-Flow, Low-Gradient Severe AS with Preserved Ejection Fraction: Controversial Outcomes Data
Howard C. Herrmann, MD reviewing Tribouilloy C et al. J Am Coll Cardiol 2015 Jan 6–13. Pibarot P and Clavel M-A. J Am Coll Cardiol 2015 Jan 6–13.